Yup.
It’s ‘interesting’ to me that less than 2 months after we get our first case we’re already injecting vaccines into volunteers.
In Washington state no less.
Are they getting the same vaccine ‘we’ will be getting assuming it works?
http://content.time.com/time/health/article/0,8599,1932366,00.html
Bkmk
Good question.
I love how the Germans revolted, against the vaccine meant for the plebs.
What on earth is wrong with Germans...
http://content.time.com/time/health/article/0,8599,1932366,00.html
from link:
Critics are calling it a two-tier health system — one for the politically well connected, another for the hoi polloi. As Germany launched its mass-vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism because it was offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another, potentially riskier vaccine to everyone else. The government had hoped that Germans would rush to health clinics to receive vaccinations against the rapidly spreading disease, but now rising anger over the different drugs may cause many people to shy away.
Nearly 7 million in 6 Bay Area [NorCal] counties ordered to ‘shelter in place’ to slow spread of COVID-19
https://ktla.com/news/california/6-bay-area-counties-to-face-shelter-in-place-order-to-slow-spread-of-covid-19/
Posted: Mar 16, 2020 / 12:23 PM PDT / Updated: Mar 16, 2020 / 09:30 PM PDT
Phase 1 of the study is intended to test the safety of three dose levels of the new vaccine — mRNA-1273 — named after the genetic material that makes up the injections and which researchers say can produce a vaccine very quickly.
“This study is the first step in the clinical development of an mRNA vaccine” against coronavirus, said Dr. Tal Zaks, chief medical officer at Moderna, in a statement.
The trial will include 45 healthy adults ages 18 to 55. Each participant will receive two shots, 28 days apart. Three different doses will be tested on 15 people each and the participants will be studied to determine whether the vaccine is safe.